These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients. Borgen E; Rypdal MC; Sosa MS; Renolen A; Schlichting E; Lønning PE; Synnestvedt M; Aguirre-Ghiso JA; Naume B Breast Cancer Res; 2018 Oct; 20(1):120. PubMed ID: 30322396 [TBL] [Abstract][Full Text] [Related]
3. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Fluegen G; Avivar-Valderas A; Wang Y; Padgen MR; Williams JK; Nobre AR; Calvo V; Cheung JF; Bravo-Cordero JJ; Entenberg D; Castracane J; Verkhusha V; Keely PJ; Condeelis J; Aguirre-Ghiso JA Nat Cell Biol; 2017 Feb; 19(2):120-132. PubMed ID: 28114271 [TBL] [Abstract][Full Text] [Related]
4. An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy. Khalil BD; Sanchez R; Rahman T; Rodriguez-Tirado C; Moritsch S; Martinez AR; Miles B; Farias E; Mezei M; Nobre AR; Singh D; Kale N; Sproll KC; Sosa MS; Aguirre-Ghiso JA J Exp Med; 2022 Jan; 219(1):. PubMed ID: 34812843 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and ΔNp63. Liu Y; Zhang P; Wu Q; Fang H; Wang Y; Xiao Y; Cong M; Wang T; He Y; Ma C; Tian P; Liang Y; Qin LX; Yang Q; Yang Q; Liao L; Hu G Nat Commun; 2021 Sep; 12(1):5232. PubMed ID: 34475402 [TBL] [Abstract][Full Text] [Related]
6. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway. Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796 [TBL] [Abstract][Full Text] [Related]
7. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase. Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954 [TBL] [Abstract][Full Text] [Related]
8. Lineage commitment pathways epigenetically oppose oncogenic Gαq/11-YAP signaling in dormant disseminated uveal melanoma. Kadamb R; Anton ML; Purwin TJ; Chua V; Seeneevassen L; Teh J; Angela Nieto M; Sato T; Terai M; Roman SR; De Koning L; Zheng D; Aplin AE; Aguirre-Ghiso J bioRxiv; 2024 Mar; ():. PubMed ID: 38496663 [TBL] [Abstract][Full Text] [Related]
9. Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells. Whang YM; Choi EJ; Seo JH; Kim JS; Yoo YD; Kim YH Cancer Chemother Pharmacol; 2005 Nov; 56(5):543-55. PubMed ID: 15959780 [TBL] [Abstract][Full Text] [Related]
10. Silencing LINC00663 inhibits inflammation and angiogenesis through downregulation of NR2F1 via EBF1 in bladder cancer. Zhong X; Sun L; Liu J; Yang X; Hou M; Wang X; Diao H RNA Biol; 2024 Jan; 21(1):9-22. PubMed ID: 39219375 [TBL] [Abstract][Full Text] [Related]
12. 5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling. Singh DK; Carcamo S; Farias EF; Hasson D; Zheng W; Sun D; Huang X; Cheung J; Nobre AR; Kale N; Sosa MS; Bernstein E; Aguirre-Ghiso JA Cell Rep; 2023 Jun; 42(6):112560. PubMed ID: 37267946 [TBL] [Abstract][Full Text] [Related]
13. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713 [TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells. Zhuang Y; Faria TN; Chambon P; Gudas LJ Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of retinoic acid-inducible transcription by COUP-TFI in human salivary gland adenocarcinoma cell line HSG. Kyakumoto S; Ota M; Sato N Biochem Cell Biol; 1999; 77(6):515-26. PubMed ID: 10668629 [TBL] [Abstract][Full Text] [Related]
16. The biology and clinical implications of prostate cancer dormancy and metastasis. Morrissey C; Vessella RL; Lange PH; Lam HM J Mol Med (Berl); 2016 Mar; 94(3):259-65. PubMed ID: 26489605 [TBL] [Abstract][Full Text] [Related]
17. A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease. Thompson VC; Day TK; Bianco-Miotto T; Selth LA; Han G; Thomas M; Buchanan G; Scher HI; Nelson CC; ; Greenberg NM; Butler LM; Tilley WD Int J Cancer; 2012 Aug; 131(3):662-72. PubMed ID: 22275114 [TBL] [Abstract][Full Text] [Related]
18. HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition. Chen H; Zhang H; Lee J; Liang X; Wu X; Zhu T; Lo PK; Zhang X; Sukumar S Cancer Res; 2007 Sep; 67(17):8007-13. PubMed ID: 17804711 [TBL] [Abstract][Full Text] [Related]
19. Osteoblastic protein kinase D1 contributes to the prostate cancer cells dormancy via GAS6-circadian clock signaling. Li G; Fan M; Zheng Z; Zhang Y; Zhang Z; Huang Z; Luo W; Zhao W; Lai X; Chen H; Zeng F; Deng F Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119296. PubMed ID: 35595103 [TBL] [Abstract][Full Text] [Related]
20. Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9. Drivdahl R; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Plymate SR Oncogene; 2004 Jun; 23(26):4584-93. PubMed ID: 15077158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]